|
|
|
|
|
00000cam0a22000004ib4500 |
001 |
BY-NLB-br62786 |
005 |
20220615100303.0 |
010 |
# |
# |
$d 2000 r.
|
100 |
# |
# |
$a 19930625d1996 u y0rusy50 ||||ca
|
101 |
0 |
# |
$a eng
|
102 |
# |
# |
$a ru
|
105 |
# |
# |
$a y 000yy
|
109 |
# |
# |
$a aa
|
200 |
1 |
# |
$a Anaerobic glycolysis as a property of malignant cells and its application aspects
|
210 |
# |
# |
$a Dubna
$d 1996
|
215 |
# |
# |
$a 15 p.
|
225 |
1 |
# |
$a Prepr.
$f Joint Inst.for Nuclear Research
$v E19-96-49)
|
300 |
# |
# |
$a Ref.:p.14-15
|
345 |
# |
# |
$9 260 экз.
|
606 |
0 |
# |
$3 BY-NLB-ar4137
$a БИОФИЗИКА
$2 DVNLB
|
606 |
0 |
# |
$3 BY-NLB-ar53431
$a ГЛИКОЛИЗ
$2 DVNLB
|
606 |
0 |
# |
$3 BY-NLB-ar13536
$a КЛЕТКИ (биол.)
$2 DVNLB
|
606 |
0 |
# |
$3 BY-NLB-ar21893
$a ОПУХОЛИ
$2 DVNLB
|
606 |
0 |
# |
$3 BY-NLB-ar7620
$a ГИПЕРГЛИКЕМИЯ
$2 DVNLB
|
606 |
0 |
# |
$3 BY-NLB-ar27325
$a РАК
$2 DVNLB
|
606 |
0 |
# |
$3 BY-NLB-ar27326
$a РАК
$2 DVNLB
|
606 |
0 |
# |
$3 BY-NLB-ar33534
$a ТЕРАПИЯ
$2 DVNLB
|
606 |
0 |
# |
$3 BY-NLB-ar4059
$a БИОЛОГИЯ КЛЕТКИ
$2 DVNLB
|
606 |
0 |
# |
$3 BY-NLB-ar4138
$a БІЯФІЗІКА
$2 DVNLB
|
606 |
0 |
# |
$3 BY-NLB-ar13537
$a КЛЕТКІ (біял.)
$2 DVNLB
|
606 |
0 |
# |
$3 BY-NLB-ar21894
$a ПУХЛІНЫ
$2 DVNLB
|
606 |
0 |
# |
$3 BY-NLB-ar7669
$a ГІПАКСІЯ
$2 DVNLB
|
606 |
0 |
# |
$3 BY-NLB-ar7621
$a ГІПЕРГЛІКЕМІЯ
$2 DVNLB
|
606 |
0 |
# |
$3 BY-NLB-ar33535
$a ТЭРАПІЯ
$2 DVNLB
|
606 |
0 |
# |
$3 BY-NLB-ar7668
$a ГИПОКСИЯ
$2 DVNLB
|
606 |
0 |
# |
$3 BY-NLB-ar4060
$a БІЯЛОГІЯ КЛЕТКІ
$2 DVNLB
|
606 |
0 |
# |
$3 BY-NLB-ar37533
$a ЦИТОПАТОЛОГИЯ
$2 DVNLB
|
675 |
# |
# |
$a 577.124.22:616-006
$v 3
$z rus
|
675 |
# |
# |
$a 576.385.5:616-006
$v 3
$z rus
|
686 |
# |
# |
$a 31.23.15
$2 rugasnti
|
686 |
# |
# |
$a 31.27.31
$2 rugasnti
|
686 |
# |
# |
$a 34.19.27
$2 rugasnti
|
700 |
# |
1 |
$3 BY-SEK-330921
$a Shmakova
$b N. L.
|
701 |
# |
1 |
$3 BY-SEK-264195
$a Korogodin
$b V. I.
|
801 |
# |
0 |
$a BY
$b BY-HM0000
$c 19930625
$g psbo
|
801 |
# |
1 |
$a BY
$b BY-HM0000
$c 20060314
$g psbo
|